According to 10x Genomics 's latest financial reports the company's current earnings (TTM) are -$0.26 B. In 2022 the company made an earning of -$0.17 B a decrease over its 2021 earnings that were of -$53.72 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.25 B | 53.58% |
2022 | -$0.17 B | 201.54% |
2021 | -$53.72 M | -89.95% |
2020 | -$0.54 B | 1622.28% |
2019 | -$31.04 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -92.57% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | -71.56% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 105.76% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.17 B | -33.95% | Jersey |